Expectations of preventative benefits and risk behaviors in a randomized trial evaluating oral HIV preexposure prophylaxis candidates
Jeremy Sugarman(Johns Hopkins Berman Institute of Bioethics), Kevin P. Weinfurt(Duke University), Marybeth McCauley(Family Health International 360), Chen Dun, Kenneth H. Mayer(Miriam Hospital), Brian W. Weir(Johns Hopkins University), Roy M. Gulick(New York University), Timothy Wilkin(Cornell University)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891